Augustine Haslett

FDA OKs Mirdametinib for Neurofibromatosis Type 1

FDA OKs Mirdametinib for Neurofibromatosis Type 1

February 11, 2025

MedPage Today) -- The FDA on Tuesday approved mirdametinib (Gomekli) for adults and kids ages 2 and up with neurofibromatosis...

Read More

Novo’s Weight Loss Drugs Removed from FDA Shortage List

Novo’s Weight Loss Drugs Removed from FDA Shortage List

February 22, 2025

‘Active recovery’ after exercise is supposed to improve performance—but does it really work?

‘Active recovery’ after exercise is supposed to improve performance—but does it really work?

February 22, 2025

The Surprising Source of Next-Gen Antibiotics: Oyster Blood

The Surprising Source of Next-Gen Antibiotics: Oyster Blood

February 22, 2025

New GLP-1 Data Reinforce CV Benefit

New GLP-1 Data Reinforce CV Benefit

February 22, 2025

Tool Predicts Whether One Bruise in Pediatric ED Signals Abuse

Tool Predicts Whether One Bruise in Pediatric ED Signals Abuse

February 22, 2025